Navarro M - Search Results

1

Glucagon-like peptide-1 (7-36) amide as a novel neuropeptide.

Blázquez E, Alvarez E, Navarro M, Roncero I, Rodríguez-Fonseca F, Chowen JA, Zueco JA. Blázquez E, et al. Among authors: navarro m. Mol Neurobiol. 1998 Oct;18(2):157-73. doi: 10.1007/BF02914270. Mol Neurobiol. 1998. PMID: 10065878 Review.

2

Increased glucagon-like peptide-1 receptor expression in glia after mechanical lesion of the rat brain.

Chowen JA, de Fonseca FR, Alvarez E, Navarro M, García-Segura LM, Blázquez E. Chowen JA, et al. Among authors: navarro m. Neuropeptides. 1999 Jun;33(3):212-5. doi: 10.1054/npep.1999.0757. Neuropeptides. 1999. PMID: 10657494

3

Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.

Rodriquez de Fonseca F, Navarro M, Alvarez E, Roncero I, Chowen JA, Maestre O, Gómez R, Muñoz RM, Eng J, Blázquez E. Rodriquez de Fonseca F, et al. Among authors: navarro m. Metabolism. 2000 Jun;49(6):709-17. doi: 10.1053/meta.2000.6251. Metabolism. 2000. PMID: 10877194

4

Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.

Navarro M, Rodriquez de Fonseca F, Alvarez E, Chowen JA, Zueco JA, Gomez R, Eng J, Blázquez E. Navarro M, et al. J Neurochem. 1996 Nov;67(5):1982-91. doi: 10.1046/j.1471-4159.1996.67051982.x. J Neurochem. 1996. PMID: 8863504

5

CB1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats.

Navarro M, Chowen J, Rocío A Carrera M, del Arco I, Villanúa MA, Martin Y, Roberts AJ, Koob GF, de Fonseca FR. Navarro M, et al. Neuroreport. 1998 Oct 26;9(15):3397-402. doi: 10.1097/00001756-199810260-00012. Neuroreport. 1998. PMID: 9855288

6

Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Navarro M, Carrera MR, Fratta W, Valverde O, Cossu G, Fattore L, Chowen JA, Gomez R, del Arco I, Villanua MA, Maldonado R, Koob GF, Rodriguez de Fonseca F. Navarro M, et al. J Neurosci. 2001 Jul 15;21(14):5344-50. doi: 10.1523/JNEUROSCI.21-14-05344.2001. J Neurosci. 2001. PMID: 11438610 Free PMC article.

7

Role of the endogenous cannabinoid system in the regulation of motor activity.

Rodríguez de Fonseca F, Del Arco I, Martín-Calderón JL, Gorriti MA, Navarro M. Rodríguez de Fonseca F, et al. Among authors: navarro m. Neurobiol Dis. 1998 Dec;5(6 Pt B):483-501. doi: 10.1006/nbdi.1998.0217. Neurobiol Dis. 1998. PMID: 9974180 Review.

8

The neurobiology of cannabinoid transmission: from anandamide signaling to higher cerebral functions and disease.

Navarro M, Rodríguez de Fonseca F. Navarro M, et al. Neurobiol Dis. 1998 Dec;5(6 Pt B):379-85. doi: 10.1006/nbdi.1998.0216. Neurobiol Dis. 1998. PMID: 9974172 Review. No abstract available.

9

Effects of delta9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells.

Rodríguez de Fonseca F, Wenger T, Navarro M, Murphy LL. Rodríguez de Fonseca F, et al. Among authors: navarro m. Brain Res. 1999 Sep 11;841(1-2):114-22. doi: 10.1016/s0006-8993(99)01809-0. Brain Res. 1999. PMID: 10546994

10

Pretreatment with subeffective doses of Rimonabant attenuates orexigenic actions of orexin A-hypocretin 1.

Crespo I, Gómez de Heras R, Rodríguez de Fonseca F, Navarro M. Crespo I, et al. Among authors: navarro m. Neuropharmacology. 2008 Jan;54(1):219-25. doi: 10.1016/j.neuropharm.2007.05.027. Epub 2007 Jun 22. Neuropharmacology. 2008. PMID: 17889909

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,674 results

Search Page

Filters